DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Rangarajan S, Kim B, Lester W. , et al.
Achievement of normal factor VIII activity following gene transfer with valoctocogene roxaparvovec (BMN 270): long- term efficacy and safety results in patients with severe hemophilia A.
Haemophilia 2018;
24: 66
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.